Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supply, especially during periods of disruption.

In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to supply. So how can companies maintain the security of supply while protecting profits?